Celltrion super antibody / Celltrion - LARVOL DELTA

Celltrion’s Covid-19 antiviral treatment enters the next phase of development (Businesswire) - "Celltrion Group today announced its successful transition to the second phase of development for an antiviral treatment to fight the novel coronavirus (COVID-19) pandemic, following the completion of the first phase of securing 300 different types of antibodies that bind to the antigen....Celltrion anticipates the candidate screening for the therapeutic monoclonal antibody (mAb) will be complete by mid-April, sooner than originally expected....'we will roll out mass production of the therapeutic antibody treatment, with a view to starting human trials this July'."

New trial